Mediavilla M D, Güezmez A, Ramos S, Kothari L, Garijo F, Sánchez Barceló E J
Department of Physiology and Pharmacology, School of Medicine, University of Cantabria, Santander, Spain.
J Pineal Res. 1997 Mar;22(2):86-94. doi: 10.1111/j.1600-079x.1997.tb00308.x.
The oncostatic effects of melatonin on the mammary gland have been studied in transgenic mice carrying the N-ras proto-oncogene under the control of the MMTV-LTR. Female (4-week-old) virgin mice with positive transgenic pedigrees were injected with melatonin (200 micrograms/mouse/ day, five times a week) or vehicle late in the evening. After 5 months of treatment, animals were sacrificed and the mammary glands were dissected for whole mounts, histology, and immunohistochemical analysis with a mouse monoclonal antibody specific for N-ras protein. Mammary glands of control transgenic mice showed different densities of hyperplastic alveolar nodules (HANs) consisting primarily of dysplastic epithelial cells with nuclear atypia and prominent nucleoli. The epithelial cells of HANs showed a high expression of N-ras while no immunostaining was detected in the unaffected mammary parenchyma. Only one (10%) of the control transgenic mice presented an infiltrating ductal carcinoma with the neoplastic cells overexpressing N-ras protein. The mammary glands of melatonin treated mice had a lower density of HANs, absence of epithelial dysplastic cells, and weak immunostaining of N-ras protein in comparison to the vehicle-treated group. None of the melatonin treated animals developed mammary carcinomas during the observation period. The lymph nodes of the inguinal mammary glands of all the vehicle-treated transgenic mice presented hyperplasia and two animals even had lymphomas, whereas in melatonin-treated animals there was less hyperplasia (two cases were atrophic) and a lack of lymphomas. We conclude that in the mammary glands of MMTV-LTR/N-ras transgenic female virgin mice, melatonin a) reduces the incidence of HANs and the expression of N-ras protein in focal hyperplastic lesions, b) completely prevents the development of epithelial cell atypia and mammary adenocarcinomas, and c) also reduces the hyperplasia of the mammary lymphoid tissue and prevents the development of lymphomas.
褪黑素对乳腺的抑癌作用已在携带受MMTV-LTR控制的N-ras原癌基因的转基因小鼠中进行了研究。具有阳性转基因谱系的雌性(4周龄)处女小鼠在傍晚时分注射褪黑素(200微克/只/天,每周5次)或溶剂。治疗5个月后,处死动物并解剖乳腺进行整体标本制作、组织学检查以及用针对N-ras蛋白的小鼠单克隆抗体进行免疫组织化学分析。对照转基因小鼠的乳腺显示出不同密度的增生性肺泡结节(HANs),主要由具有核异型性和明显核仁的发育异常上皮细胞组成。HANs的上皮细胞显示N-ras高表达,而在未受影响的乳腺实质中未检测到免疫染色。对照转基因小鼠中只有一只(10%)出现浸润性导管癌,肿瘤细胞过度表达N-ras蛋白。与溶剂处理组相比,褪黑素处理小鼠的乳腺中HANs密度较低,无上皮发育异常细胞,且N-ras蛋白免疫染色较弱。在观察期内,褪黑素处理的动物均未发生乳腺癌。所有溶剂处理的转基因小鼠腹股沟乳腺的淋巴结均出现增生,甚至有两只动物发生淋巴瘤,而褪黑素处理的动物增生较少(两例萎缩)且无淋巴瘤。我们得出结论,在MMTV-LTR/N-ras转基因雌性处女小鼠的乳腺中,褪黑素a)降低HANs的发生率以及局灶性增生性病变中N-ras蛋白的表达,b)完全防止上皮细胞异型性和乳腺腺癌的发生,c)还减少乳腺淋巴组织的增生并防止淋巴瘤的发生。